Hormone Therapy Linked To Ovarian Cancer Risk

NEW YORK (Reuters Health) - The risk of ovarian cancer is increased in women who use unopposed estrogen for 10 years or more, and in those taking estrogen and progestin for 5 years or more, according to a report in The Journal of the National Cancer Institute.>>> Discuss This Story

MORE ON THIS TOPIC